281 related articles for article (PubMed ID: 33659920)
1. Recent advances in the understanding and management of liposarcoma.
Haddox CL; Riedel RF
Fac Rev; 2021; 10():1. PubMed ID: 33659920
[TBL] [Abstract][Full Text] [Related]
2. An overview on liposarcoma subtypes: Genetic alterations and recent advances in therapeutic strategies.
M S A; K C; Bhargavan RV; Somanathan T; Subhadradevi L
J Mol Histol; 2024 Jun; 55(3):227-240. PubMed ID: 38696048
[TBL] [Abstract][Full Text] [Related]
3. Lipomatous tumors.
Weiss SW
Monogr Pathol; 1996; 38():207-39. PubMed ID: 8744279
[TBL] [Abstract][Full Text] [Related]
4. Histology driven systemic therapy of liposarcoma-ready for prime time?
Grethlein SJ
Transl Gastroenterol Hepatol; 2018; 3():96. PubMed ID: 30603732
[TBL] [Abstract][Full Text] [Related]
5. Myxoid pleomorphic liposarcoma is distinguished from other liposarcomas by widespread loss of heterozygosity and significantly worse overall survival: a genomic and clinicopathologic study.
Dermawan JK; Hwang S; Wexler L; Tap WD; Singer S; Vanderbilt CM; Antonescu CR
Mod Pathol; 2022 Nov; 35(11):1644-1655. PubMed ID: 35672466
[TBL] [Abstract][Full Text] [Related]
6. [Clinical value of fluorescence
Wang W; Li X; Liu P; Dong Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):228-233. PubMed ID: 37042132
[TBL] [Abstract][Full Text] [Related]
7. A contemporary review of myxoid adipocytic tumors.
Creytens D
Semin Diagn Pathol; 2019 Mar; 36(2):129-141. PubMed ID: 30853315
[TBL] [Abstract][Full Text] [Related]
8. Established and Experimental Systemic Treatment Options for Advanced Liposarcoma.
Schöffski P
Oncol Res Treat; 2022; 45(9):525-543. PubMed ID: 35609512
[TBL] [Abstract][Full Text] [Related]
9. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration.
Mariño-Enríquez A; Hornick JL; Dal Cin P; Cibas ES; Qian X
Cancer Cytopathol; 2014 Feb; 122(2):128-37. PubMed ID: 24227706
[TBL] [Abstract][Full Text] [Related]
10. What's new in adipocytic neoplasia?
Creytens D
Virchows Arch; 2020 Jan; 476(1):29-39. PubMed ID: 31501988
[TBL] [Abstract][Full Text] [Related]
11. Differences in recurrence and survival of extremity liposarcoma subtypes.
Vos M; Koseła-Paterczyk H; Rutkowski P; van Leenders GJLH; Normantowicz M; Lecyk A; Sleijfer S; Verhoef C; Grünhagen DJ
Eur J Surg Oncol; 2018 Sep; 44(9):1391-1397. PubMed ID: 29673808
[TBL] [Abstract][Full Text] [Related]
12. Multiple Recurrent Atypical Lipomatous Tumors/Well-Differentiated Liposarcomas and Dedifferentiated Liposarcomas Treated with Multiple Surgical Resections: A Case Report.
Maejima A; Hirozane T; Yamaguchi S; Mori T; Asano N; Kikuta K; Hirabayashi K; Takeuchi K; Nakayama R; Nakamura M; Matsumoto M
Case Rep Oncol; 2023; 16(1):1223-1231. PubMed ID: 38045430
[TBL] [Abstract][Full Text] [Related]
13. Liposarcoma of the pleural cavity.
Kawai T; Nakashima H; Washimi K; Yokose T; Matsuo T; Nakayama M; Shinohara N; Kuroda H; Ishida K; Akiba J; Ishikawa M; Urabe S; Shiraishi J; Shiraishi T; Sakamoto A; Matsukuma S
Hum Pathol; 2023 Jun; 136():105-113. PubMed ID: 37023867
[TBL] [Abstract][Full Text] [Related]
14. Liposarcoma: new entities and evolving concepts.
Dei Tos AP
Ann Diagn Pathol; 2000 Aug; 4(4):252-66. PubMed ID: 10982304
[TBL] [Abstract][Full Text] [Related]
15. The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfall.
Kuczkiewicz-Siemion O; Wiśniewski P; Dansonka-Mieszkowska A; Grabowska-Kierył M; Olszewska K; Goryń T; Prochorec-Sobieszek M; Rutkowski P; Szumera-Ciećkiewicz A
Pathol Res Pract; 2021 Sep; 225():153555. PubMed ID: 34325315
[TBL] [Abstract][Full Text] [Related]
16. Detection of
Rekhi B; Karnik N; Agrawal R; Shetty O; Patkar S
Indian J Pathol Microbiol; 2022; 65(1):65-75. PubMed ID: 35074968
[TBL] [Abstract][Full Text] [Related]
17. Liposarcomas of the mediastinum and thorax: a clinicopathologic and molecular cytogenetic study of 24 cases, emphasizing unusual and diverse histologic features.
Boland JM; Colby TV; Folpe AL
Am J Surg Pathol; 2012 Sep; 36(9):1395-403. PubMed ID: 22895273
[TBL] [Abstract][Full Text] [Related]
18. Primary Extremity Liposarcoma: MRI Features, Histopathology, and Clinical Outcomes.
Wortman JR; Tirumani SH; Jagannathan JP; Tirumani H; Shinagare AB; Hornick JL; Ramaiya NH
J Comput Assist Tomogr; 2016; 40(5):791-8. PubMed ID: 27224232
[TBL] [Abstract][Full Text] [Related]
19. Managing Liposarcomas: Cutting Through the Fat.
Manji GA; Schwartz GK
J Oncol Pract; 2016 Mar; 12(3):221-7. PubMed ID: 26962163
[TBL] [Abstract][Full Text] [Related]
20. Myxoid Pleomorphic Liposarcoma.
Dermawan JK
Surg Pathol Clin; 2024 Mar; 17(1):25-29. PubMed ID: 38278605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
